시장보고서
상품코드
1322267

세계의 근접치료 시드 시장 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2031년)

Brachytherapy Seeds Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

발행일: | 리서치사: Transparency Market Research | 페이지 정보: 영문 170 Pages | 배송안내 : 2-10일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

근접치료 시드 시장-보고서 범위

세계의 근접치료 시드(Brachytherapy Seeds) 시장에 대한 TMR 보고서는 과거 및 현재의 성장 동향과 2023년에서 2031년까지 예측 기간 동안 시장 지표의 귀중한 통찰력을 얻을 수 있는 기회를 연구하고 있습니다. 2023년을 기준년도, 2031년을 예측년도로 하여 2017년부터 2031년까지 근접치료 시드 시장의 수익을 게재합니다. 또한 2023년부터 2031년까지 세계의 근접치료 시드 시장 CAGR(%)도 제공합니다.

보고서는 광범위한 조사를 거쳐 작성되었습니다. 1차 조사에서는 조사 활동의 대부분이 이루어졌으며 분석가들은 주요 오피니언 리더, 산업 리더, 오피니언 제조사와 인터뷰를 실시했습니다. 2차 조사는 근접치료 시드 시장을 이해하기 위해 주요 기업의 제품 문헌, 연례 보고서, 보도 자료 및 관련 문서 참조를 포함합니다.

세계의 근접치료 시드 시장 경쟁 상황을 자세히 파악하고 있습니다. 세계의 근접치료 시드 시장에서 활동하는 주요 플레이어가 확인되었으며, 이들 각각은 다양한 속성의 관점에서 프로파일링됩니다. 회사 개요, 재무 상황, 최근 동향 및 SWOT는 이 보고서에 소개된 세계의 근접치료 시드 시장 플레이어 속성입니다.

목차

제1장 서문

제2장 전제 조건 및 연구 조사 방법

제3장 주요 요약

제4장 시장 개요

  • 소개
  • 개요
  • 시장 역학
  • 전 세계 시장 분석 및 예측(2017-2031년)
  • Porter’s Five Forces 분석

제5장 주요 통찰

  • 주요 인수 합병
  • 주요 방사성 시드 종류/브랜드 분석
  • 특허분석
  • 시장 분야에서 활동하는 톱 3 플레이어
  • COVID-19 팬데믹의 산업에 대한 영향(밸류 체인 및 단기·중기·장기적인 영향)

제6장 시장 분석 및 예측 : 방사성 시드 종류별

  • 소개 및 정의
  • 주요 발견/개발
  • 시장 금액 예측 : 방사성 시드 종류별(2017-2031년)
    • 요오드-125
    • 팔라듐-103
    • 세슘-131
    • 기타
  • 시장 매력 분석 : 방사성 시드 종류별

제7장 시장 분석 및 예측 : 방법별

  • 소개 및 정의
  • 주요 발견/개발
  • 시장 금액 예측 : 방법별(2017-2031년)
    • HRD 근접치료
    • LDR 근접치료
  • 시장 매력 분석 : 방법별

제8장 시장 분석 및 예측 : 용도별

  • 소개 및 정의
  • 주요 발견/개발
  • 시장 금액 예측 : 용도별(2017-2031년)
    • 부인과 암
    • 전립선암
    • 유방암
    • 뇌종양
    • 기타
  • 시장 매력 분석 : 용도별

제9장 세계 시장 분석 및 예측 : 최종 사용자별

  • 소개 및 정의
  • 주요 발견/개발
  • 시장 금액 예측 : 최종 사용자별(2017-2031년)
    • 병원
    • 암 연구소
    • 기타
  • 시장 매력 분석 : 최종 사용자별

제10장 시장 분석 및 예측 : 지역별

  • 주요 조사 결과
  • 시장 금액 예측 : 지역별(2017-2031년)
    • 북미
    • 유럽
    • 아시아 태평양 지역
    • 남미
    • 중동 및 아프리카
  • 시장 매력 분석 : 지역별

제11장 북미 시장 분석 및 예측

제12장 유럽 시장 분석 및 예측

제13장 아시아 태평양 시장 분석 및 예측

제14장 남미 시장 분석 및 예측

제15장 중동 및 아프리카 시장 분석 및 예측

제16장 경쟁 상황

  • 시장 진입 기업-경쟁 매트릭스(기업의 계층 및 규모별)
  • 시장 점유율 분석 : 기업별(2021년)
  • 기업 개요
    • Argon Medical
    • Carl Zeiss AG
    • Eckert &Ziegler BEBIG
    • Elektra AB
    • Icad, Inc.
    • Isoaid
    • Isoray Medical, Inc.
    • Merit Medical Systems, Inc.
    • Siemens AG
    • Theragenics Corporation
LYJ 23.10.10

Brachytherapy Seeds Market - Scope of Report

TMR's report on the global Brachytherapy Seeds Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Brachytherapy Seeds Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Brachytherapy Seeds Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Brachytherapy Seeds Market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Brachytherapy Seeds Market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Brachytherapy Seeds Market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Brachytherapy Seeds Market.

The report delves into the competitive landscape of the global Brachytherapy Seeds Market. Key players operating in the global Brachytherapy Seeds Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Brachytherapy Seeds Market profiled in this report.

Key Questions Answered in Global Brachytherapy Seeds Market Report:

  • What is the sales/revenue generated by mobile photo printer across all regions during the forecast period?
  • What are the opportunities in the global Brachytherapy Seeds Market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Brachytherapy Seeds Market - Research Objectives and Research Approach

The comprehensive report on the global Brachytherapy Seeds Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Brachytherapy Seeds Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Brachytherapy Seeds.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Brachytherapy Seeds Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Brachytherapy Seeds Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)
    • 4.4.2. Market Volume/Unit Shipments Projections
  • 4.5. Porter's Five Forces Analysis

5. Key Insights

  • 5.1. Key Mergers & Acquisitions
  • 5.2. Key Radioactive Seed Type/Brand Analysis
  • 5.3. Patent Analysis
  • 5.4. Top 3 Players Operating in the Market Space
  • 5.5. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

6. Global Brachytherapy Seeds Market Analysis and Forecast, by Radioactive Seed Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Radioactive Seed Type, 2017-2031
    • 6.3.1. Iodine-125
    • 6.3.2. Palladium-103
    • 6.3.3. Cesium-131
    • 6.3.4. Others
  • 6.4. Market Attractiveness Analysis, by Radioactive Seed Type

7. Global Brachytherapy Seeds Market Analysis and Forecast, by Technique

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Technique, 2017-2031
    • 7.3.1. HRD Brachytherapy
    • 7.3.2. LDR Brachytherapy
  • 7.4. Market Attractiveness Analysis, by Technique

8. Global Brachytherapy Seeds Market Analysis and Forecast, by Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Application, 2017-2031
    • 8.3.1. Gynecological Cancer
    • 8.3.2. Prostate Cancer
    • 8.3.3. Breast Cancer
    • 8.3.4. Brain Cancer
    • 8.3.5. Others
  • 8.4. Market Attractiveness Analysis, by Application

9. Global Brachytherapy Seeds Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Hospitals
    • 9.3.2. Cancer Institutes
    • 9.3.3. Others
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global Brachytherapy Seeds Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2017-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness Analysis, By Region

11. North America Brachytherapy Seeds Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Radioactive Seed Type, 2017-2031
    • 11.2.1. Iodine-125
    • 11.2.2. Palladium-103
    • 11.2.3. Cesium-131
    • 11.2.4. Others
  • 11.3. Market Value Forecast, by Technique, 2017-2031
    • 11.3.1. HRD Brachytherapy
    • 11.3.2. LDR Brachytherapy
  • 11.4. Market Value Forecast, by Application, 2017-2031
    • 11.4.1. Gynecological Cancer
    • 11.4.2. Prostate Cancer
    • 11.4.3. Breast Cancer
    • 11.4.4. Brain Cancer
    • 11.4.5. Others
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Hospitals
    • 11.5.2. Cancer Institutes
    • 11.5.3. Others
  • 11.6. Market Value Forecast, by Country, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Radioactive Seed Type
    • 11.7.2. By Technique
    • 11.7.3. By Application
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Brachytherapy Seeds Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Radioactive Seed Type, 2017-2031
    • 12.2.1. Iodine-125
    • 12.2.2. Palladium-103
    • 12.2.3. Cesium-131
    • 12.2.4. Others
  • 12.3. Market Value Forecast, by Technique, 2017-2031
    • 12.3.1. HRD Brachytherapy
    • 12.3.2. LDR Brachytherapy
  • 12.4. Market Value Forecast, by Application, 2017-2031
    • 12.4.1. Gynecological Cancer
    • 12.4.2. Prostate Cancer
    • 12.4.3. Breast Cancer
    • 12.4.4. Brain Cancer
    • 12.4.5. Others
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Hospitals
    • 12.5.2. Cancer Institutes
    • 12.5.3. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Radioactive Seed Type
    • 12.7.2. By Technique
    • 12.7.3. By Application
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Brachytherapy Seeds Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Radioactive Seed Type, 2017-2031
    • 13.2.1. Iodine-125
    • 13.2.2. Palladium-103
    • 13.2.3. Cesium-131
    • 13.2.4. Others
  • 13.3. Market Value Forecast, by Technique, 2017-2031
    • 13.3.1. HRD Brachytherapy
    • 13.3.2. LDR Brachytherapy
  • 13.4. Market Value Forecast, by Application, 2017-2031
    • 13.4.1. Gynecological Cancer
    • 13.4.2. Prostate Cancer
    • 13.4.3. Breast Cancer
    • 13.4.4. Brain Cancer
    • 13.4.5. Others
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Hospitals
    • 13.5.2. Cancer Institutes
    • 13.5.3. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Radioactive Seed Type
    • 13.7.2. By Technique
    • 13.7.3. By Application
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Brachytherapy Seeds Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Radioactive Seed Type, 2017-2031
    • 14.2.1. Iodine-125
    • 14.2.2. Palladium-103
    • 14.2.3. Cesium-131
    • 14.2.4. Others
  • 14.3. Market Value Forecast, by Technique, 2017-2031
    • 14.3.1. HRD Brachytherapy
    • 14.3.2. LDR Brachytherapy
  • 14.4. Market Value Forecast, by Application, 2017-2031
    • 14.4.1. Gynecological Cancer
    • 14.4.2. Prostate Cancer
    • 14.4.3. Breast Cancer
    • 14.4.4. Brain Cancer
    • 14.4.5. Others
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Hospitals
    • 14.5.2. Cancer Institutes
    • 14.5.3. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Radioactive Seed Type
    • 14.7.2. By Technique
    • 14.7.3. By Application
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Brachytherapy Seeds Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Radioactive Seed Type, 2017-2031
    • 15.2.1. Iodine-125
    • 15.2.2. Palladium-103
    • 15.2.3. Cesium-131
    • 15.2.4. Others
  • 15.3. Market Value Forecast, by Technique, 2017-2031
    • 15.3.1. HRD Brachytherapy
    • 15.3.2. LDR Brachytherapy
  • 15.4. Market Value Forecast, by Application, 2017-2031
    • 15.4.1. Gynecological Cancer
    • 15.4.2. Prostate Cancer
    • 15.4.3. Breast Cancer
    • 15.4.4. Brain Cancer
    • 15.4.5. Others
  • 15.5. Market Value Forecast, by End-user, 2017-2031
    • 15.5.1. Hospitals
    • 15.5.2. Cancer Institutes
    • 15.5.3. Others
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Radioactive Seed Type
    • 15.7.2. By Technique
    • 15.7.3. By Application
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (by tier and size of companies)
  • 16.2. Market Share Analysis, by Company, 2021
  • 16.3. Company Profiles
    • 16.3.1. Argon Medical
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Carl Zeiss AG
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Eckert & Ziegler BEBIG
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Elektra AB
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Icad, Inc.
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Isoaid
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Isoray Medical, Inc.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Merit Medical Systems, Inc.
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Siemens AG
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Theragenics Corporation
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제